"Digoxin is a substrate of P-glycoprotein and drugs that inhibit P-glycoprotein, such as verapamil, may increase digoxin bioavailability with the potential for digoxin toxicity (DuBuske 2005)."
Source:Clinical Pharmacy and Therapeutics, 4th ed. by Roger Walker and Cate Whittlesea
No comments:
Post a Comment